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Previewsreduced GEF-H1 activity, supporting
a proposed hierarchy of GEF activities in
cytokinesis (Birkenfeld et al., 2007). This
is interesting because diploid and tetra-
ploid megakaryocytes represent distinct
decision points in physiologic control of
blood platelet counts. A young megakar-
yocyte that fortuitously completes furrow
ingression in the first endomitotic cycle
will generate two diploid daughters, as
occurs in normal mitosis and as Gao
et al. observed in 13% of 2N cells (Gao
et al., 2012). In imposing a barrier to tetra-
ploidy, GEF-H1 activity thus controls the
switch from a precursor capable of pro-
ducing new megakaryocytes to a postmi-
totic cell that is committed to platelet
synthesis. It thus serves a homeostatic
need to balance the proportions of pre-
cursors that can continue to prolif-
erate and mature cells that will release
platelets and die. Perhaps GEF-H1 is
unable to meet the demands of cytoki-
nesis in large cells with multipolar spin-
dles, or perhaps abundant microtubule
polymers in these cells inactivate it,
rendering cytokinesis in polyploid cells
wholly dependent on ECT2-triggered
RhoA activation.
Can the mechanisms of endomitosis
shed light on tumor aneuploidy? Like472 Developmental Cell 22, March 13, 2012 ªendomitotic megakaryocytes, tumor cells
may carry supernumerary centrosomes,
possibly reflecting a prior history of tetra-
ploidy resulting from abortive cell cycles.
The role of abortive cytokinesis in tumori-
genesis, however, remains unclear and
largely speculative. Multipolar mitotic
spindles, well documented in megakaryo-
cytes, are rare and often fatal in other
cells; instead, extra centrosomes cluster
during mitosis and form pseudo-bipolar
spindles, triggering faulty segregation of
individual chromosomes (Ganem et al.,
2009). Gao et al. note that mutation
of the tumor suppressor gene TP53, a
common event in human cancers, is
associated with GEF-H1 overexpression
and that a truncated, active form of
GEF-H1 induces tumors in mice. In cells
facing a choice between mitosis and
endomitosis, as 2N megakaryocytes do,
excess GEF-H1 might well favor mitotic
divisions, but does this apply in cells that
do not ordinarily undergo endomitosis?
Further investigation will provide clarity
on this question. Meanwhile, elucidation
of a regulatory mechanism for megakar-
yocyte endomitosis solves an old mystery
and suggests candidate pathways to
evaluate in the early history of aneuploid
cancers.2012 Elsevier Inc.REFERENCES
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Research on solid tumors has had limited emphasis on interactions between transformed cells and their
neighbors within the epithelium. Leung and Brugge (2012) use cultured breast cancer acini to demonstrate
the importance of local interactions between normal and transformed epithelial cells, with important implica-
tions for our understanding of epithelial cancers.Oncogenes and tumor suppressors,
epigenetics, tumor-stroma interactions,
and immune system modulation all play
important roles in early-stage tumor
progression. Less appreciated are inter-actions between transformed cells and
their immediate neighbors. In a recent
article in Nature, Leung and Brugge
(2012) now strengthen growing evidence
that transformed cells interact early andintimately with their epithelial neighbors.
They use a simple, inspired approach to
explore these interactions in three-dimen-
sional breast epithelial morphogenesis
cultures, pushing us to reconsider how
Figure 1. Epithelial Boundaries and Acinar Translocation Models
(A) In the Drosophila wing, Src transformation leads to loss of junctional markers (P120-catenin, green) specifically at the tumor boundary (arrows).
(B) In human squamous cell carcinoma, E-cadherin (brown) is lost specifically at the tumor boundary (arrow).
(C) Possible migration scenarios for oncogene-expressing clones with the potential to translocate through epithelial layers.
(A) and (B) are from Vidal et al. (2006, 2010).
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Previewsearly steps in tumor progression are
triggered.
Work in developmental model systems
has provided a potential blueprint for
how initial transformation alters cells’
interactions within their host epithelium.
For example, Wu et al. (2010) demon-
strated that Ras-transformed epithelial
cells in Drosophila exchange signals with
their immediate neighbors through the
cell polarity protein Scribble and across
their epithelial milieu through local JNK
activity, resulting in increased tumor
expansion. Other work has emphasized
cell competition, in which growth rates
within a clonal patch of transformed cells
leads to local signaling that influences
the cells’ neighbors.
Perhaps more directly related to Leung
and Brugge’s work is in vivo work by Vidal
et al. (2006, 2010) on Src and Ras-Src
models. Activation of Src throughout the
emerging Drosophila wing disc led strictly
to overgrowth. However, activation of
Src—or Ras/Src but not Ras alone—
within a discrete patch of cells led to their
migration specifically at the boundary of
the incipient tumor and its untransformed
neighbors. The release of cells from the
epithelium was due to local activation of a
Src/E-cadherin/Rho/Jnk/MMP cascade;
human squamous cell carcinomas dis-
played evidence for this boundary effect
as well (Figure 1). This and other work
has led to the suggestion that trans-
formed cells are recognized as abnormal
by their neighbors—potentially through
local junctional interactions—and aresignaled to leave the epithelium. The cells
avoid death by anoikis, however, because
they express high levels of caspase inhib-
itors and are motile due to activation of
actin remodeling proteins. The result: the
first steps toward tumor cell migration
away from the original site.
Leung and Brugge now explore these
issues in human mammary epithelial cells.
They target transgenes to individual
MCF10A cells within mammary acini that
form in 3D culture, a model pioneered by
the Bissell laboratory (Weaver et al.,
1997) that recapitulates important aspects
of breast cancer progression. Inducing
proliferation in cells throughout the acinar
epithelium by overexpressing c-Myc or
activated AKT (myr-AKT) does not lead to
migration in this model. However, intro-
ducing the ErbB2 oncogene into individual
cells is sufficient to direct their migration
and translocation into the acinar lumen,
modeling aspects of some forms of early-
stage ductal cell carcinoma in situ (DCIS).
Translocation is MAPK dependent but
proliferation independent. Simply by dis-
rupting cells’ interaction with the extracel-
lularmatrix through expression of themet-
alloproteinase MMP14 or knockdown of
the integrin binding, cytoskeletal protein
Talin-1 also directs migration, suggesting
that release from the epithelium and base-
ment membrane may require this key
step. Addition of myr-AKT or c-Myc then
promotesclonal expansion,butonlywithin
the lumen: simply overexpressing these
oncogenes or cancer-related cell-cycle
regulators fails to direct cell translocation.Developmental Cell 2Further exploration of individual cells
within acini suggests the importance of
local cell-cell interactions. For example,
ErbB2-transformed cells that fail to
migrate also fail to proliferate; proliferation
is restored by disrupting cell junctions
(E-cadherin), pointing to the potential
importance of local interactions and junc-
tions on the behavior of transformed cells.
The authors astutely point to the implica-
tions of their work regarding the permis-
sive nature of luminal compartments for
clonal selection: a single cell released
into the breast cancer lumen represents
a clone no longer receiving restrictive
signals from its original neighbors.
This work has a number of implications
for breast and possibly other epithelial
cancers. Perhaps most important is
further emphasis on approaching tumors
as disruptions of epithelial patterning and
integrity. A long body of work has
explored how cells communicate locally
during development and, to a lesser
extent, homeostasis. This work provides
a rich opportunity to further explore the
subtle interactions at tumor boundaries.
Work on local microenvironments has
often emphasized stromal compart-
ments, which support tumor progression.
Leung and Brugge’s data provide a fine-
grained view of the epithelial microenvi-
ronment, suggesting that local dominions
within the epithelial structure prevail, es-
tablishing growth-restrictive (i.e., basal,
luminal cell layers) and growth-permissive
(i.e., luminal space) microenvironments.
In their experiments, the oncogene2, March 13, 2012 ª2012 Elsevier Inc. 473
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Previews‘‘dominance’’ or ‘‘addiction’’ that drives
the proliferative state relies on the micro-
environment, a long-standing and well-
supported hypothesis (Boudreau and
Bissell, 1998). Presumably, only onco-
genes that promote both proliferation
and translocation can efficiently propel
clonal expansion into the luminal compart-
ment. ErbB2, which activates multiple
pathways, provides this complexity of
signaling, perhaps accounting for its acti-
vation in a third of breast tumors.
The ability of junctional components to
regulate growth and migration in both
human and fly models raises the question
as to the nature of this regulation. Perhaps
junctional proteins such as E-cadherin
serve a classical tumor suppressor func-
tion; abundant evidence points to the
ability of E-cadherin to signal, through
RhoA and potentially JNK, maintaining
epithelial identity. Furthermore, junctional
proteins, including E-cadherin, are direct
targets of Src, a kinase that regulates
migration and is directly activated by
ErbB2. Whether ErbB2-dependent migra-
tion within acini involves Src signaling in
a manner similar to observations in
Drosophila remains an open question.
Another potential culprit is loss of apical-
basal polarity in the transformed cell:
ErbB2 can disrupt epithelial polarity by
associating with the Par6-aPKC cell
polarity complex (Aranda et al., 2006).
What does this model tell us specifically
about breast cancer? The MCF10A
system recapitulates features of some
forms of ductal cell carcinoma in situ474 Developmental Cell 22, March 13, 2012 ª(Debnath et al., 2002). Recently the pres-
ence of disseminated breast cancer cells
in bone marrow was described in patients
carrying ‘‘preinvasive’’ lesions (Schardt
et al., 2005). This suggests that transloca-
tion to the stroma and into circulation
already occurs in early-stage lesions and
thus may require far fewer genetic and
epigenetic changes than previously
believed. Leung and Bruggemodel move-
ment in one direction: luminal. But inva-
sion in the opposite direction, stromal, is
the key step in establishing a dissemi-
nated tumor cell subpopulation. Are the
two linked?
Advanced-stage tumor cells must
eventually access the stroma, suggesting
three possible scenarios (Figure 1C). In
the first, luminal translocation is unneces-
sary, and transformed cells also invade
outward to access the stroma and vascu-
lature. Perhaps a model using mammary
epithelium isolated from fresh murine
tissues or reconstituted with myoepithe-
lial and other stromal cells—not present
in the Leung and Brugge model—could
determine whether translocation into the
lumen, occupancy, and eventual expan-
sion is a prerequisite. ECM tension (i.e.,
collagen stiffness) may play a role in
determining the directionality of this
movement (Levental et al., 2009). Alterna-
tively but not exclusively, only after tumor
cells evolve and become ‘‘capacitated’’
within the luminal compartment can their
progeny retrotranslocate back through
the epithelial layer to the stroma. Finally,
an interesting hypothesis is that early2012 Elsevier Inc.disseminated tumor cells, still responsive
to growth-restrictive microenvironments,
can nonetheless migrate and disseminate
before entering a protracted dormancy
state in distant stromal or epithelial
tissues. By targeting single cells, Leung
and Brugge provide a useful roadmap
for further exploring these issues.
REFERENCES
Aranda, V., Haire, T., Nolan, M.E., Calarco, J.P.,
Rosenberg, A.Z., Fawcett, J.P., Pawson, T., and
Muthuswamy, S.K. (2006). Nat. Cell Biol. 8, 1235–
1245.
Boudreau, N., and Bissell, M.J. (1998). Curr. Opin.
Cell Biol. 10, 640–646.
Debnath, J., Mills, K.R., Collins, N.L., Reginato,
M.J., Muthuswamy, S.K., and Brugge, J.S.
(2002). Cell 111, 29–40.
Leung, C.T., and Brugge, J.S. (2012). Nature 482,
410–413.
Levental, K.R., Yu, H., Kass, L., Lakins, J.N., Ege-
blad, M., Erler, J.T., Fong, S.F., Csiszar, K., Giac-
cia, A., Weninger, W., et al. (2009). Cell 139,
891–906.
Schardt, J.A., Meyer, M., Hartmann, C.H., Schu-
bert, F., Schmidt-Kittler, O., Fuhrmann, C., Polzer,
B., Petronio, M., Eils, R., and Klein, C.A. (2005).
Cancer Cell 8, 227–239.
Vidal, M., Larson, D.E., and Cagan, R.L. (2006).
Dev. Cell 10, 33–44.
Vidal, M., Salavaggione, L., Ylagan, L., Wilkins, M.,
Watson, M., Weilbaecher, K., and Cagan, R.
(2010). Am. J. Pathol. 176, 3007–3014.
Weaver, V.M., Petersen, O.W., Wang, F., Larabell,
C.A., Briand, P., Damsky, C., and Bissell, M.J.
(1997). J. Cell Biol. 137, 231–245.
Wu, M., Pastor-Pareja, J.C., and Xu, T. (2010).
Nature 463, 545–548.
